The safety and efficacy of topical tacrolimus for treatment of atopic dermatitis (its licensed indication) has been well demonstrated in numerous large-scale randomized controlled trials and ...

More patients with atopic dermatitis achieved mild disease severity by 1 month of treatment with adjuvant dupilumab and tacrolimus vs dupilumab alone. A greater proportion of patients with atopic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Pimecrolimus, ...

Atopic dermatitis is one of the most common chronic inflammatory skin diseases worldwide and is also the most common form of eczema. Although infants and children are most often affected, adults can ...

Topical tacrolimus and pimecrolimus are not recommended for the treatment of mild atopic eczema or as first-line treatments for atopic eczema of any severity. Topical tacrolimus is recommended, within ...

Tacrolimus eye ointment for steroid-refractory vernal keratoconjunctivitis significantly improved symptoms and signs after 12 weeks but did not significantly improve visual acuity, according to a ...

Tacrolimus is one of the newer immunosuppressants that act by inhibiting T-cell activation and cytokine release. It is approved for the treatment of atopic dermatitis, and its safety and efficacy have ...